Document:

EXHIBIT 10.26

AMENDMENT TO PROCESSING AND
 PROCESSING AGREEMENT

The Agreement made and entered into June 27,2000 by and between Clover Farms Dairy Company and NuVim Inc., is hereby amended as follows effective April 1, 2003

Article 9.1 is deleted

Article 9.1 A is added to the agreement.

Article 9.1 A   Processing charges provided under this agreement shall be prepaid by NuVim to Clover Farms, as mutually agreed. Failure to prepay, may at the option of Clover Farms, cause Clover Farms to refuse to Process and Package product as provided by this agreement. Such refusal to process shall not be considered default by Clover Farms under any other provision of this agreement.

	
  
 
  	
  
NUVIM,   INC
  	
  
 
  	
  
Date
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
By
  	
  
PAUL YOUNG
  	
  
 
  	
  
April 14, 2003
  
	
  
 
  	
  
 
  	
  

  	
  
 
  	
  
 
  
	
  
 
  	
  
Title
  	
  
Vice President
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
CLOVER FARMS   DAIRY COMPANY
  	
  
 
  	
  
Date
  
	
   
  	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
By
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  

  	
  
 
  	
  

  
	
  
 
  	
  
TitleEXHIBIT 10.27

NUVIM, INC.

SECOND AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT

        
            THIS SECOND
AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT (this “Agreement”), dated
as of August 2, 2004, by and among NUVIM, INC., a Delaware corporation (the “Company”),
each of the MANAGEMENT STOCKHOLDERS (as defined below), each of the PRINCIPAL STOCKHOLDERS
(as defined below), the holders of shares of Series A Preferred Stock, par value $0.00001
per share (“Series A Stock”), of the Company (the “SERIES A INVESTORS”
and, together with the Management Stockholders and the Principal Stockholders, the “Original
 Investors”), and the holders of shares of Series C Convertible Preferred Stock, par value $0.00001
per share (“Series C Stock”), of the Company (the “SERIES C INVESTORS” and, together
with the Series A Investors, the “Equity Investors”), who are now or who
may hereafter become, signatories and/or parties hereto.  Each of the Management
Stockholders, Principal Stockholders, Series A Investors and Series C Investors is sometimes
referred to herein individually as a “Stockholder” and collectively, the “Stockholders.”

                    WHEREAS, the Company and the Original Investors entered into a Stockholders’ Agreement, dated as of March 14, 2000 (the “Original Agreement”);

                    WHEREAS, the Original Investors and the Series C Investors agreed to amend and restate the Original Agreement and entered into that certain Amended and Restated Stockholders’ Agreement, dated as of September 13, 2002 (the “Amended Agreement”); and

                    WHEREAS, the Original Investors and the Series C Investors desire to amend and restate the Amended Agreement in the manner set forth in this Agreement and have consented to such amendment and restatement as set forth in this Agreement.

                    NOW, THEREFORE, the parties hereto hereby agree as follows:

                    1.          Certain Definitions.  As used in this Agreement, the following terms shall have the following respective meanings:

                                “Affiliate” shall mean, with respect to any non-individual Stockholder, any person or entity that, directly or indirectly, controls or is controlled by or is under common control with such Stockholder.  As used in this definition “control” shall mean possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other partnership interests, by contract or otherwise).

                                “Amended and Restated Registration Rights Agreement” shall mean the Amended and Restated Registration Rights Agreement of even date herewith among the Company and the Equity Investors.

                                “Commission” shall mean the Securities and Exchange Commission, or any other Federal agency at the time administering the Securities Act.

                                “Common Stock” shall mean the common stock, par value $0.00001 per share, of the Company, including, without limitation, the common stock issuable upon the conversion of the Company’s Series A Stock and Series C Stock.

                                “Equity Securities” shall mean shares of Common Stock, Series A Stock and Series C Stock and any other securities of the Company issued in exchange for, upon conversion or in substitution of, or otherwise in respect of, such shares.

                                “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the applicable time.

                                “Extraordinary Event” shall mean (i) a consolidation or merger of the Company with or into any other entity, or any other corporate reorganization, in which the stockholders of the Company immediately prior to such consolidation, merger or reorganization own capital stock of the entity surviving such merger, consolidation or reorganization representing less than fifty (50%) percent of the combined voting power of the outstanding securities of such entity immediately after such consolidation, merger or reorganization, or any other transaction or series of related transactions in which capital stock representing in excess of fifty (50%) percent of the Company’s voting power is transferred to any single entity or group of related entities; or (ii) a sale, lease or
other disposition of all or substantially all of the assets of the Company.

                                “Family Group” shall mean, with respect to any Stockholder who is an individual, (i) such Stockholder’s spouse, former spouse, descendants (whether natural or adopted), parents and their descendants and any spouse of the foregoing persons (collectively, “relatives”) or (ii) the trustee, fiduciary or personal representative of such Stockholder or any trust established solely for the benefit of the such Stockholder and/or such Stockholder’s relatives.

                                “IPO” shall mean an initial public offering of the Company’s equity securities.

                                “Liquidity Event” shall mean (i) the consummation of an IPO, (ii) any merger, consolidation or business combination of the Company with any other entity other than an affiliate of the Company and pursuant to which the Company is not the surviving entity, (iii) any sale of all or substantially all of the securities of the Company by the holders thereof, (iv) any sale of all or substantially all of the assets of the Company, (v) any bona fide offer by a third-party, subject to customary conditions and approval by the Company’s Board of Directors, to purchase all or substantially all of the outstanding Series A Stock and Series C Stock of the Company held by the Equity Investors or (vi) any offer by the Company to repurchase all or substantially all of the
outstanding Series A Stock and Series C Stock held by the Equity Investors.

                                “Management Stockholders” shall mean Stolle Milk Biologics, Inc., Richard P. Kundrat, Donald F. Farley, Paul Young, John L. Sullivan, David E. Grein, Dominic A. DeBellis, Lawrence E. Hicks, Peter B. Hutt, Dr. Myron Solberg and Dr. Lee Beck.

- 2 -

                                “Offering” shall mean the offering of units consisting of shares of Series C Stock by the Company pursuant to the Memorandum.

                                “Permitted Transferee(s)” shall mean, (i) in the case of any individual Stockholder, transferees who receive shares pursuant to applicable laws of descent and distribution and members of such Stockholder’s Family Group and (ii) in the case of a non-individual Stockholder, such Stockholder’s Affiliates; provided, that, in each case, such transferee shall have agreed to take all such Transferred shares subject to, and to be fully bound by, the terms of this Agreement applicable to such shares by duly executing and delivering a joinder to this Agreement to the Secretary of the Company prior to the effectiveness of such Transfer (unless such Transfer is pursuant to applicable laws of descent and distribution, in which case, such executed joinder
shall be delivered as soon as reasonably possible after such Transfer thereunder).

                                “Placement Agency Agreement” shall mean the Placement Agency Agreement dated January 13, 2000 between the Company and Spencer Trask Ventures, Inc. (the “Series A Placement Agent”).

                                “Principal Stockholder(s)” shall mean any person, entity or group that beneficially owns, directly, ten (10%) percent of the Company’s capital stock immediately preceding the date hereof.

                                “Pro Rata Share” shall mean, in any particular instance, the proportion by which the number of Equity Securities owned by an Equity Investor bears to the aggregate number of Equity Securities of the Company, calculated on a fully-diluted basis.

                                “Public Sale” shall mean any sale of Equity Securities to the public pursuant to an offering registered under the Securities Act or pursuant to the provisions of Rule 144 (or any similar rule or rules then in effect permitting public sale without registration) under the Securities Act.

                                “Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.

                                “Transfer” shall mean any voluntary or involuntary, direct or indirect sale, transfer, conveyance, assignment, gift, donation, assignment, pledge, hypothecation, delivery or other disposition by a Stockholder of Equity Securities, but shall not include any redemption or repurchase of Equity Securities by the Company.  “Transferred” shall mean any change in ownership by means of a Transfer.

                    2.          Restrictive Legend Requirements.  Each certificate representing any shares of Equity Securities shall, except as otherwise provided in this Section 2 or in Section 3 hereof, bear a legend substantially in the following form:

	
  
 
  	
  
(a)
  	
  
THE TRANSFER OR SALE OF THIS SECURITY IS SUBJECT TO   THE TERMS OF AN AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT DATED AS OF   ______________, 2002 A COPY OF WHICH IS ON FILE AT THE OFFICE OF THE COMPANY.
  

- 3 -

	
  
 
  	
  
(b)
  	
  
THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE   SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES OR BLUE SKY LAWS   AND MAY NOT BE TRANSFERRED OR OTHERWISE SOLD UNLESS IT HAS BEEN REGISTERED   UNDER SUCH ACT AND ALL SUCH APPLICABLE LAWS OR AN EXEMPTION FROM REGISTRATION   IS AVAILABLE.
  

A certificate shall not bear the legend set forth in the second paragraph above (or any portion thereof) if, in the opinion of counsel reasonably satisfactory to the Company, the securities represented thereby may be publicly sold without registration under the Securities Act and any applicable state securities laws.

                    3.         General Restrictions on Transfer.

                    (a)        A Stockholder may Transfer shares thereof only (i) in a Public Sale, (ii) pursuant to a valid exemption from registration under the Securities Act; provided, that such Stockholder complies with Section 2 and Section 3(b) hereof or, (iii) subject to Section 2 hereof, to a Permitted Transferee.

                    (b)        Prior to any proposed Transfer of any of the Equity Securities, the holder thereof shall give written notice (a “Transfer Notice”) to the Company of his or its intention to effect such Transfer.  Each such Transfer Notice shall describe the manner of the proposed Transfer and, if requested by the Company, shall be accompanied by an opinion of counsel reasonably satisfactory to the Company to the effect that the proposed Transfer may be effected without registration under the Securities Act and any applicable state securities laws, whereupon the holder of such shares shall be entitled to effect such Transfer in accordance with the terms of its Transfer Notice; provided, however, that the Company shall have the right to refuse any purported Transfer that would cause the
Company to lose its exemption from registration under Section 12(g) of the Exchange Act.  Each certificate representing any of the Equity Securities transferred as above provided shall bear the legend set forth in Section 2, except that such certificate shall not bear the legend in clause (b) thereof (or any portion thereof) if: (a) such Transfer is being made in accordance with the provisions of Rule 144(k) (or any other rule permitting public sale without registration) under the Securities Act or (b) the opinion of counsel referred to above is to the further effect that the transferee and any subsequent transferee (other than an Affiliate of the Company) would be entitled to Transfer such securities in a Public Sale without registration under the Securities Act.  The restrictions provided for in this Section 3(b) shall not apply to Equity Securities that are not required to bear the legend prescribed by Section 2 in accordance with the provisions of such Section.

                    (c)        If
  any Transfer of Equity Securities is made or suffered by any Stockholder without
  the giving of prior written notice as required by this Agreement, such purported
  Transfer shall be void.  Further, if any of the Equity Securities are the
  subject of a Transfer that is made not in accordance with the terms and conditions
  of this Agreement, such Transfer shall be void ab initio. 
  In enforcing this provision, the Company may hold and refuse to transfer any
  of the Equity Securities or any certificate therefor tendered to it for transfer
  in addition to, and without prejudice to, any and all other rights or remedies
  as may be available to the Company.

- 4 -

                    4.        Preemptive Rights.

                    (a)       If, at any time prior to the consummation of an Extraordinary Event or the IPO, the Company desires to issue any Equity Securities to any third-party or parties other than in connection with such Extraordinary Event or IPO, the Company shall promptly deliver a written notice (the “Preemptive Right Notice”) to each Equity Investor setting forth a description and the number of Equity Securities proposed to be issued, the proposed purchase price and the terms of such issuance.  Upon receipt of the Preemptive Right Notice, each Equity Investor shall have the right to elect to purchase, at the price and on the terms stated in the Preemptive Right Notice, up to such Equity Investor’s Pro-Rata Share of such Securities.  Such election shall be made by written notice to the Company within
thirty (30) calendar days after receipt by such Equity Investor of the Preemptive Right Notice (the “Acceptance Period”), whereupon the Company shall promptly sell and such Equity Investor shall buy, upon the terms specified, the number of shares of such Securities agreed to be purchased by such Equity Investor.  In the event that less than all Equity Investors choose to exercise such preemptive right, no Equity Investor shall have any right to subscribe to any additional securities to be issued.

                    (b)        The Company shall be free at any time during a period of ninety (90) days following the expiration of the applicable Acceptance Period to offer and sell to any third party or parties the number of shares of Equity Securities not purchased by the Equity Investors at a price and on payment terms no less favorable to the Company than those specified in the Preemptive Right Notice; provided, however, that if such third-party sale or sales are not consummated within such ninety (90) day period, the Company shall not thereafter issue or sell such securities without again complying with this Section 4.

                    (c)        The preemptive rights contained in this Section 4 shall not apply to Equity Securities issued or sold (i) as a stock dividend or upon any subdivision, split or combination of the outstanding shares of capital stock, (ii) pursuant to, or upon exercise or conversion of, subscriptions, warrants, options, convertible securities, convertible notes or other rights that are disclosed in the Subscription Agreement as being issued or outstanding on the date hereof, (iii) pursuant to the grant of options, or the exercise of options, to purchase Equity Securities granted to directors, officers, employees or consultants of the Company in connection with their service to the Company, and pursuant to the Company’s 2000 and/or 2001 Equity Incentive Plans or the Company’s 2002 Employee
Stock Option Plan subject to limitations imposed by the Company’s Board of Directors (appropriately adjusted to reflect stock splits, stock dividends, combinations of shares and the like), (iv) pursuant to the issuance and/or exercise of warrants issued to the Series A Placement Agent in connection with any future financing, (v) in connection with any merger, acquisition, business combination or other reorganization, (vi) in connection with equity issuances to strategic or institutional investors, as determined by the Company’s Board of Directors, and (vii) in connection with the issuance of any so-called “equity kickers” to banks or institutional investors.

                    (d)        Notwithstanding anything contained herein to the contrary, the preemptive rights set forth in this Section 4 may be waived by a written waiver duly executed by Equity Investors holding more than fifty (50%) percent of the total number of shares of Series A Stock and Series C Stock held by all Equity Investors at the time of such waiver.

- 5 -

                    (e)        In the event that, in connection with a Preemptive Right Notice, a Series C Investor fails to purchase the Series C Investor’s Pro Rata Share, the Series C Investor shall forfeit the “full-ratchet” anti-dilution price protection as set fort in the Certificate of Designation for the Series C Stock.

                    5.        Lock-up.  Notwithstanding anything to the contrary contained in this Agreement, until the earlier of the March 31, 2005 or one (1) year following the completion of an IPO (or sooner if permitted by the managing underwriter), the Management Stockholders and the Principal Stockholders hereby agree not to Transfer any of the Company’s securities owned by, or issuable to, the Management Stockholders or the Principal Stockholders, except in case of sales, transfers or other dispositions to Permitted Transferees.  The Company’s Board of Directors may require that any such Permitted Transferee be made subject to a voting agreement, pursuant to which the transferring stockholder retains the right to vote all of the transferred shares until the second (2nd) anniversary
of the date hereof.  In addition, if, by March 31, 2005, the Company has registered any of its securities under the Securities Act, which registration is effective, the terms of the “lock-up” set forth in this Section 5 shall be extended for the Management Stockholders and the Principal Stockholders and any Permitted Transferees for a period of not less than one (1) year from the effective date of such registration.

                    6.        Voting for Designated Directors.  The Principal Stockholders, the Management Stockholders and the Series A Investors hereby agree to vote, as stockholders and at any meeting of the Board of Directors at, or by means of any written consent pursuant to, which directors are to be elected, their shares of Equity Securities for the election of all persons designated by the Series A Placement Agent pursuant to the Placement Agency Agreement for election to the Company’s Board of Directors.

                    7.        Event of Election.  If the Company shall not have otherwise effected a Liquidity Event by the fourth (4th) anniversary of the date hereof, then, notwithstanding the provisions of Section 7 hereof, the majority of the Equity Investors still holding Equity Securities shall have the right to elect a majority of the members of the Company’s Board of Directors and shall have the right to remove directors as necessary and to create vacancies for the election of such nominees (“Event of Election”).  The Event of Election shall continue until the occurrence of a Liquidity Event, whereupon any directors nominated and elected pursuant to this Section 8 shall resign from the Board of Directors and those directors who were removed to create vacancies, if any, shall
be reinstated to the Board of Directors.

                    8.        Information.  

                    (a)      For a period of the earlier of five (5) years from the date hereof or the effectiveness of an IPO, the Company shall furnish each of the Stockholders with the following:

	
  
 
  	
  
 
  	
  
i.
  	
  
within one hundred twenty (120) days after the end   of each fiscal year of the Company, audited financial statements of the   Company for such fiscal year, which shall include a statement of operations   for each such fiscal year, a balance 
  

- 6 -

 

 

	
  
 
  	
  
 
  	
  
 
  	
  
sheet as at the last day thereof and a statement of   cash flows and stockholders’ equity (deficit) prepared in accordance with   United States generally accepted accounting principles consistently applied   and accompanied by the report of the Company’s independent certified public   accountants;
  
	
   
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
ii.
  	
  
within forty-five (45) days after the end of each   fiscal quarter of the Company, a quarterly report, showing the progress and   status of the Company; and
  
	
  
 
  	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
iii.
  	
  
within ninety (90) days after the end of each fiscal   year of the Company, an annual report setting forth the financial position   and outlook of the Company.
  

                    (b)      If, for any period, the Company shall have any subsidiary or subsidiaries whose accounts are consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing Section 8(a) shall be the consolidated financial statements of the Company and all such consolidated subsidiaries.

                    9.      Termination.  This Agreement shall automatically terminate upon the occurrence of any of the following events:

                    (a)      a bankruptcy, receivership or dissolution of the Company;

                    (b)      the voluntary agreement by and among the Company and the Stockholders holding on the termination date more than fifty (50%) percent of the total number of shares of Equity Securities; or

                    (c)      the consummation of a Liquidity Event.

                    10.      Arbitration of Disputes. This Agreement shall be governed by and construed in accordance with the laws of the State of New York relating to contracts entered into and to be performed wholly within such State.  Each Stockholder agrees that any dispute arising out of or in connection with this Agreement shall be resolved as follows.  Such Stockholder shall attempt in good faith to resolve such dispute.  If, notwithstanding such efforts, such dispute is not resolved within thirty (30) days from the date written notice thereof is delivered by such Stockholder to the Company, such dispute shall be settled by arbitration by, and in accordance with, the then-existing Code of Arbitration of the National Association of Securities Dealers, Inc. (“NASD”).  Hearings with regard to
such dispute shall be held at the offices of the NASD in the City and County of New York and judgment upon any award rendered pursuant to this Section 11 may be entered in any court of competent jurisdiction.  Any award rendered pursuant to the terms and conditions set forth herein shall be final and binding.  Any such arbitration shall be conducted before a single arbitrator designated in accordance with the rules of the NASD.  Any party to the arbitration shall be entitled to costs and expenses and reasonable attorney’s fees in the event it prevails in any claims, actions, awards or judgment under this Agreement.

- 7 -

                    11.      Miscellaneous.

                    (a)      References.  All references to “Sections” contained herein are, unless specifically indicated otherwise, references to sections of this Agreement. Whenever herein the singular number is used, the same shall include the plural where appropriate, and words of any gender shall include each other gender where appropriate.

                    (b)      Captions.  The captions, headings and arrangements used in this Agreement are for convenience only and do not in any way affect, limit, amplify or modify the terms and provisions hereof.

                    (c)      Notices.  All notices, requests, consents and other communications hereunder shall be in writing and shall be delivered in person, mailed by certified or registered mail, return receipt requested, or sent by telecopier or telex, addressed (i) if to the Company, at 12 Route 17 North, Suite 210, Paramus, New Jersey 07652; and (ii) if to any other party hereto, at the address of such party set forth beneath such party’s signature to this Agreement.  Any consent, approval, notice, request or demand required or permitted by this Agreement must be in writing and shall be deemed to have been given when actually received by the party to whom notice is sent.

                    (d)      Successors and Assigns.  This Agreement shall be binding upon and inure to the benefit of the Stockholders and the Company and their respective successors, heirs, personal representatives and assigns, including, but not limited to, any Permitted Transferee of Equity Securities hereunder.

                    (e)      Invalid Provisions.  If any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws effective during the term of this Agreement, such provision shall be fully severable; this Agreement shall be construed and enforced as if such illegal, invalid or unenforceable provision had never been included in this Agreement, and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of each such illegal, invalid or unenforceable provision, there shall be deemed added automatically as a part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable
provision as may be possible and legal, valid and enforceable.

                    (f)      Amendments.  This Agreement may be amended at any time and from time to time, in whole or in part, by an instrument in writing setting forth the particulars of such amendment, which shall be duly executed by the Company and the Stockholders holding at the time of such amendment more than fifty (50%) percent of the total number of shares of Equity Securities held by all Stockholders.

                    (g)      Multiple Counterparts.  This Agreement may be executed in a number of identical counterparts, each of which, for all purposes, shall be deemed an original, and all of which shall collectively constitute one agreement; provided, however, that in making proof of this Agreement, it shall not be necessary to produce or account for more than one such counterpart.  It is not necessary that each Stockholder execute the same counterpart, so long as identical counterparts are executed by the Company and each Stockholder.  

- 8 -

                    (h)      Enforcement.  It is specifically agreed and understood that monetary damages will not adequately compensate the breach of this Agreement and this Agreement shall therefore be specifically enforceable, and any breach or threatened breach of this Agreement shall be the proper subject of a temporary or permanent injunction or restraining order.  Further, each party hereto and their successors, heirs, representatives and assigns waive any claim or defense that there is an adequate remedy at law for such breach or threatened breach.

                    EXECUTED on the date first written above and binding on each party from and after the date such party executes this Agreement or a counterpart hereof.

	
  
COMPANY:
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
NUVIM,   INC.
  	
  
 
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
By:
  	
  
/s/ RICHARD P. KUNDRAT
  	
  
 
  
	
  
 
  	
  

  	
  
 
  
	
  
Name:
  	
  
Richard P. Kundrat
  	
  
 
  
	
  
Title:
  	
  
President
  	
  
 
  

- 9 -

	
  PRINCIPAL   STOCKHOLDERS:
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
SPENCER TRASK   SPECIALTY GROUP,   LLC
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
By:
  	
  
/s/ DONALD F. FARLEY
  	
  
 
  
	
  
 
  	
  

  	
  
 
  
	
  Name:
  	
  
Donald F. Farley
  	
  
 
  
	
  
Title:  
  	
  
President
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
STOLLE MILK   BIOLOGICS, INC.
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
By:
  	
  
/s/ DONALD F. FARLEY
  	
  
 
  
	
   
  	
  

  	
  
 
  
	
  
Name:
  	
  
Donald F. Farley
  	
  
 
  
	
  
Title:
  	
  
President
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
MANAGEMENT   STOCKHOLDERS:
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
/s/ RICHARD   P. KUNDRAT
  	
  
 
  
	
  
 
  	
  

  	
  
 
  
	
   
  	
  
Richard P. Kundrat
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
/s/ DONALD F. FARLEY
  	
  
 
  
	
  
 
  	
  

  	
  
 
  
	
  
 
  	
  
Donald F. Farley
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
/s/ LAWRENCE E. HICKS
  	
  
 
  
	
   
  	
  

  	
  
 
  
	
  
 
  	
  
Lawrence E. Hicks
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
/s/ PAUL YOUNG
  	
  
 
  
	
  
 
  	
  

  	
  
 
  
	
  
 
  	
  
Paul Young
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
/s/ JOHN L. SULLIVAN
  	
  
 
  
	
   
  	
  

  	
  
 
  
	
  
 
  	
  
John L. Sullivan
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
/s/ DOMINIC DEBELLIS
  	
  
 
  
	
  
 
  	
  

  	
  
 
  
	
  
 
  	
  
Dominic DeBellis
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
/s/ PETER B. HUTT
  	
  
 
  
	
  
 
  	
  

  	
  
 
  
	
  
 
  	
  
Peter B. Hutt
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
/s/ DR. LEE   BECK
  	
  
 
  
	
  
 
  	
  

  	
  
 
  
	
  
 
  	
  
Dr. Lee Beck
  	
  
 
  

- 10 -

EQUITY INVESTORS

	
  
/s/
  	
  
 
  
	
  

  	
  
 
  
	
  
Name:
  	
  
 
  
	
  
Address:
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
/s/
  	
  
 
  
	
  

  	
  
 
  
	
  
Name:
  	
  
 
  
	
  Address:
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
/s/
  	
  
 
  
	
  

  	
  
 
  
	
  
Name:
  	
  
 
  
	
  
Address:
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
/s/
  	
  
 
  
	
  

  	
  
 
  
	
  
Name:
  	
  
 
  
	
  Address:
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
/s/
  	
  
 
  
	
  

  	
  
 
  
	
  
Name:
  	
  
 
  
	
  
Address:
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
/s/
  	
  
 
  
	
  

  	
  
 
  
	
  
Name:
  	
  
 
  
	
  Address:
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
/s/
  	
  
 
  
	
  

  	
  
 
  
	
  
Name:
  	
  
 
  
	
  
Address:
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
/s/
  	
  
 
  
	
  

  	
  
 
  
	
  
Name:
  	
  
 
  
	
  Address:
  	
   
  

- 11 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}]]